Lynn Malec – The New Director of the CCBD and Pharmacy at Children’s Wisconsin
Versiti Inc shared on LinkedIn:
”Versiti is proud to announce the promotion of Lynn Malec, MD, MSc, to Program Director of the Comprehensive Center for Bleeding Disorders (CCBD) and Pharmacy at Children’s Wisconsin.
Since joining Versiti in 2016, Dr. Malec has led transformative advances in bleeding disorder care, including launching our gene therapy program for hemophilia B, which made Versiti one of the first centers in the U.S. to administer the FDA-approved therapy HEMGENIX.
Her internationally recognized research and compassionate leadership continue to expand access to breakthrough treatments and whole-person care for patients and families.
Learn more about our commitment to advancing hope through science.”
More winner stories featured in Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support